Burth Jonathan 4
4 · Vita Coco Company, Inc. · Filed Jun 12, 2026
Research Summary
AI-generated summary of this filing
Vita Coco COO Jonathan Burth Sells 30,000 Shares
What Happened
- Jonathan Burth, Chief Operating Officer of Vita Coco (COCO), exercised stock options to acquire a total of 30,000 shares (23,575 and 6,425 shares) at an exercise price of $10.18 per share (total exercise cost reported $305,340). On the same day (2026-06-11) he sold 30,000 shares in an open-market transaction at $80.00 per share, generating proceeds of $2,400,000. The filing shows corresponding derivative-conversion entries at $0, which reflect the options being converted into shares rather than a separate cash sale.
Key Details
- Transaction date: 2026-06-11; Form 4 filed 2026-06-12 (appears timely).
- Exercises: 23,575 @ $10.18 ($239,946) and 6,425 @ $10.18 ($65,394) — total 30,000 acquired for $305,340.
- Sale: 30,000 shares @ $80.00 = $2,400,000 proceeds; sale effected pursuant to a Rule 10b5-1 trading plan (footnote F1).
- Derivative entries at $0 reflect conversion/exercise of options into shares (not a cash sale).
- Shares owned after these transactions: not specified in the provided filing.
- Vesting/option notes: filing footnotes indicate a mix of fully vested, time-based, and performance-based option tranches; some performance tranches vested earlier (e.g., tranches satisfied on Feb 20, 2026). The options exercised were exercisable per the filing.
Context
- This sequence (exercise then sale of the same number of shares on the same day) is effectively a monetization of vested options; because the sale was executed under a pre-established Rule 10b5-1 plan, it was pre-scheduled rather than an ad-hoc market sale. The filing is factual and does not state Burth’s motivation; retail investors often view purchases as stronger bullish signals, while option exercises followed by planned sales are commonly tax- or liquidity-driven.
Insider Transaction Report
Form 4
Burth Jonathan
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2026-06-11$10.18/sh+23,575$239,946→ 81,485 total - Exercise/Conversion
Common Stock
2026-06-11$10.18/sh+6,425$65,394→ 87,910 total - Sale
Common Stock
[F1]2026-06-11$80.00/sh−30,000$2,400,000→ 57,910 total - Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
[F2]2026-06-11−23,575→ 0 totalExercise: $10.18Exp: 2030-02-10→ Common Stock (23,575 underlying) - Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
[F3]2026-06-11−6,425→ 34,525 totalExercise: $10.18Exp: 2030-02-10→ Common Stock (6,425 underlying)
Holdings
- 34,125
Non-Qualified Stock Option (Right to Buy)
[F2]Exercise: $10.18Exp: 2031-01-11→ Common Stock (34,125 underlying) - 58,043
Non-Qualified Stock Option (Right to Buy)
[F4]Exercise: $15.00Exp: 2031-10-21→ Common Stock (58,043 underlying) - 42,980
Non-Qualified Stock Option (Right to Buy)
[F5]Exercise: $15.36Exp: 2032-08-15→ Common Stock (42,980 underlying) - 14,025
Non-Qualified Stock Option (Right to Buy)
[F6]Exercise: $16.91Exp: 2033-03-10→ Common Stock (14,025 underlying) - 14,205
Non-Qualified Stock Option (Right to Buy)
[F7]Exercise: $16.91Exp: 2033-03-10→ Common Stock (14,205 underlying) - 8,746
Non-Qualified Stock Option (Right to Buy)
[F8]Exercise: $26.18Exp: 2034-03-04→ Common Stock (8,746 underlying) - 13,218
Non-Qualified Stock Option (Right to Buy)
[F9]Exercise: $33.36Exp: 2035-03-04→ Common Stock (13,218 underlying)
Footnotes (9)
- [F1]The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The stock option is fully vested and currently exercisable.
- [F3]The stock option is eligible to vest in four tranches if certain performance conditions for each tranche of the option are met by the target date for the applicable performance condition(s) and expire relative to each tranche if the performance conditions for such tranche are not met by the final target date. The performance conditions were partially met and as a result, the first tranche of the option were timely satisfied, resulting in vesting of the option as to 18,200 shares on February 6, 2024. The performance conditions applicable to the fourth tranche of the option were timely satisfied, resulting in vesting of the option as to 22,750 shares on February 20, 2026.
- [F4]The stock option vests in four equal annual installments beginning on November 27, 2022.
- [F5]The stock option vests in three equal annual installments beginning on August 15, 2025.
- [F6]The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026.
- [F7]The stock option vests in four equal annual installments beginning on March 10, 2024.
- [F8]The stock option vests in four equal annual installments beginning on March 4, 2025.
- [F9]The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
Signature
/s/ Alison Klein, Attorney-in-Fact for Jonathan Burth|2026-06-12